Concepedia

Neil Buss

NB

Statistics

Publications

16

Citations

983

H-Index

15

Active since

1992

Affiliations

Roche (Switzerland)(Current)

La Roche College

National Centre for Clinical Research on Emerging Drugs

Roche (United Kingdom)

UNSW Sydney

Neil Buss is an author at Roche (Switzerland) specializing in antiretroviral therapy, pharmacology, and antiviral therapy.

Publications per year

1992–2023

16

Publications

16

Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir

Gary J. Muirhead, Maria Wulff, Anitra Fielding et al. · British Journal of Clinical Pharmacology · 2000 · 184 citations · Full text

, , +13

Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials

Mark Nelson, Keikawus Arastéh, Bonaventura Clotet et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 151 citations

, , +17

Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive Patients

Ronald Gieschke, B. Fotteler, Neil Buss et al. · Clinical Pharmacokinetics · 1999 · 99 citations

, , +15

Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults

J Michael Kilby, Greg Sfakianos, Nick Gizzi et al. · Antimicrobial Agents and Chemotherapy · 2000 · 85 citations

, , +17

Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration

Neil Buss, Paul Snell, Jürgen Bock et al. · British Journal of Clinical Pharmacology · 2001 · 83 citations · Full text

, , +17

1–5 of 16